Clinical trials
Immunoglobulin G4-Related Disease trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Active, not recruiting | 3 |
| Recruiting | 2 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 2 |
| Mayo Clinic | 2 |
| Acepodia Biotech, Inc. | 1 |
| Emory University | 1 |
| Massachusetts General Hospital | 1 |
| Matthew C. Baker | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| Principia Biopharma, a Sanofi Company | 1 |
| Sanofi | 1 |
| Stanford University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immunoglobulin G4-Related Disease | 14 |
| Acquired Immunodeficiency Syndrome | 1 |
| Arthritis | 1 |
| Arthritis, Juvenile | 1 |
| Arthritis, Rheumatoid | 1 |
| Autoimmune Diseases | 1 |
| Autoimmune Lymphoproliferative Syndrome | 1 |
| Autoimmune Pancreatitis | 1 |
| Communicable Diseases | 1 |
| Epstein-Barr Virus Infections | 1 |
Trials
Showing 51 to 14 of 14. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.